Miss Shunping Han
Shunping graduated from Zhejiang Chinese Medical University (China) with her bachelor’s degree of pharmacy in 2014 and then continued her first MRes study in pharmaceutics from 2014 to 2017, under the supervision of Professor Fanzhu Li. During this 3-year MRes study, she looked into the construction of the targeting drug delivery system, especially focussing on the modification of PAMAM dendrimers as drug carriers for glioma therapy. She then continued her second MRes study of drug discovery and development at the Chemistry Department, Imperial College London. Her research focused on metal organic frameworks (MOFs) synthesis and modification as drug vehicles under the guidance from Dr. Rob Davies, Professor Paul Lickiss and Professor Jane Mitchell. She has been awarded the King’s-China Scholarship Council to continue her PhD under the supervision of Professor Khuloud Al-Jamal at The Institute of Pharmaceutical Science, KCL. Her current project involves the modification and functionalization of gold nanoparticles applied for cancer immunotherapy.